Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$3.44 - $4.24 $46,440 - $57,240
-13,500 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$3.33 - $4.55 $3,330 - $4,550
-1,000 Reduced 6.9%
13,500 $55,000
Q1 2021

May 10, 2021

BUY
$4.19 - $5.99 $8,380 - $11,980
2,000 Added 16.0%
14,500 $62,000
Q4 2020

Feb 11, 2021

SELL
$3.27 - $4.87 $76,845 - $114,445
-23,500 Reduced 65.28%
12,500 $49,000
Q3 2020

Nov 13, 2020

BUY
$2.99 - $5.96 $55,614 - $110,856
18,600 Added 106.9%
36,000 $133,000
Q2 2020

Aug 11, 2020

SELL
$1.15 - $3.41 $345 - $1,023
-300 Reduced 1.69%
17,400 $59,000
Q1 2020

May 08, 2020

BUY
$1.34 - $2.32 $9,380 - $16,239
7,000 Added 65.42%
17,700 $24,000
Q4 2019

Feb 07, 2020

BUY
$1.42 - $2.17 $690 - $1,054
486 Added 4.76%
10,700 $16,000
Q3 2019

Oct 31, 2019

SELL
$1.75 - $2.47 $2,625 - $3,705
-1,500 Reduced 12.81%
10,214 $21,000
Q2 2019

Aug 09, 2019

SELL
$1.79 - $2.61 $1,074 - $1,566
-600 Reduced 4.87%
11,714 $29,000
Q1 2019

Apr 24, 2019

SELL
$2.42 - $3.83 $2,904 - $4,596
-1,200 Reduced 8.88%
12,314 $32,000
Q4 2018

Jan 29, 2019

SELL
$2.46 - $3.87 $6,150 - $9,675
-2,500 Reduced 15.61%
13,514 $41,000
Q3 2018

Oct 26, 2018

SELL
$3.29 - $6.29 $4,277 - $8,177
-1,300 Reduced 7.51%
16,014 $55,000
Q2 2018

Aug 10, 2018

SELL
$2.99 - $4.99 $4,485 - $7,485
-1,500 Reduced 7.97%
17,314 $81,000
Q1 2018

May 01, 2018

BUY
$3.11 - $5.12 $9,796 - $16,128
3,150 Added 20.11%
18,814 $60,000
Q4 2017

Feb 07, 2018

SELL
$4.61 - $7.04 $137,908 - $210,601
-29,915 Reduced 65.63%
15,664 $77,000
Q3 2017

Nov 09, 2017

BUY
$5.88 - $7.11 $268,004 - $324,066
45,579
45,579 $313,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.22B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.